186 related articles for article (PubMed ID: 11696455)
1. Loss of heterozygosity on chromosomes 9q and 16p in atypical adenomatous hyperplasia concomitant with adenocarcinoma of the lung.
Takamochi K; Ogura T; Suzuki K; Kawasaki H; Kurashima Y; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Esumi H
Am J Pathol; 2001 Nov; 159(5):1941-8. PubMed ID: 11696455
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in the tuberous sclerosis gene associated regions in adenocarcinoma of the lung accompanied by multiple atypical adenomatous hyperplasia.
Suzuki K; Ogura T; Yokose T; Nagai K; Mukai K; Kodama T; Nishiwaki Y; Esumi H
Int J Cancer; 1998 Aug; 79(4):384-9. PubMed ID: 9699531
[TBL] [Abstract][Full Text] [Related]
3. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
4. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
Gradowski JF; Mantha GS; Hunt JL; Dacic S
Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the TSC1 gene in adenocarcinoma of the lung.
Takamochi K; Ogura T; Yokose T; Ochiai A; Nagai K; Nishiwaki Y; Suzuki K; Esumi H
Lung Cancer; 2004 Dec; 46(3):271-81. PubMed ID: 15541811
[TBL] [Abstract][Full Text] [Related]
6. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of hallmark cancer genes in atypical adenomatous hyperplasia of the lung.
Licchesi JD; Westra WH; Hooker CM; Herman JG
Clin Cancer Res; 2008 May; 14(9):2570-8. PubMed ID: 18451218
[TBL] [Abstract][Full Text] [Related]
8. A case of double primary adenocarcinoma of the lung with multiple atypical adenomatous hyperplasia.
Anami Y; Matsuno Y; Yamada T; Takeuchi T; Nakayama H; Hirohashi S; Noguchi M
Pathol Int; 1998 Aug; 48(8):634-40. PubMed ID: 9736412
[TBL] [Abstract][Full Text] [Related]
9. [Fine deletion mapping on chromosome 8p21 - 8p22 in adenocarcinoma of lung].
Shao S; Sun W; Zhang J; An Q; Xiao T; Yang P; Cheng S; Gao Y
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):740-2. PubMed ID: 12126542
[TBL] [Abstract][Full Text] [Related]
10. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis.
Ali-Fehmi R; Khalifeh I; Bandyopadhyay S; Lawrence WD; Silva E; Liao D; Sarkar FH; Munkarah AR
Int J Gynecol Pathol; 2006 Jul; 25(3):223-9. PubMed ID: 16810057
[TBL] [Abstract][Full Text] [Related]
11. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
[TBL] [Abstract][Full Text] [Related]
12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of atypical adenomatous hyperplasia and adenocarcinoma of the lung by use of DNA ploidy and morphometric analysis.
Yokozaki M; Kodama T; Yokose T; Matsumoto T; Mukai K
Mod Pathol; 1996 Dec; 9(12):1156-64. PubMed ID: 8972475
[TBL] [Abstract][Full Text] [Related]
14. Is high-grade adenomatous hyperplasia an early bronchioloalveolar adenocarcinoma?
Ullmann R; Bongiovanni M; Halbwedl I; Fraire AE; Cagle PT; Mori M; Papotti M; Popper HH
J Pathol; 2003 Nov; 201(3):371-6. PubMed ID: 14595748
[TBL] [Abstract][Full Text] [Related]
15. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
16. Atypical adenomatous hyperplasia and adenocarcinoma of the human lung: their heterology in form and analogy in immunohistochemical characteristics.
Mori M; Tezuka F; Chiba R; Funae Y; Watanabe M; Nukiwa T; Takahashi T
Cancer; 1996 Feb; 77(4):665-74. PubMed ID: 8616758
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis.
Sato T; Seyama K; Fujii H; Maruyama H; Setoguchi Y; Iwakami S; Fukuchi Y; Hino O
J Hum Genet; 2002; 47(1):20-8. PubMed ID: 11829138
[TBL] [Abstract][Full Text] [Related]
18. Monoclonality of atypical adenomatous hyperplasia of the lung.
Niho S; Yokose T; Suzuki K; Kodama T; Nishiwaki Y; Mukai K
Am J Pathol; 1999 Jan; 154(1):249-54. PubMed ID: 9916939
[TBL] [Abstract][Full Text] [Related]
19. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.
Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y
Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930
[TBL] [Abstract][Full Text] [Related]
20. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]